Skip to main content
Premium Trial:

Request an Annual Quote

Shares in Affymetrix Jump 6.95 Percent on News of Record Sales Growth

NEW YORK, Jan. 5 (GenomeWeb News) - Shares in Affymetrix were up 6.95 percent at $36.30 in late-afternoon trading after the company said sales during the fourth quarter of 2004 increased 17 percent to more than $100 million.

 

Affymetrix said that the product-related revenues were a record for the company, and investors flocked to buy the stock. The shares traded as high as $37.24 this morning.

 

As GenomeWeb News reported this morning, the microarray giant also said it has $10 million worth of orders for products it plans to release within the next six months, including new SNP-genotyping arrays and automated instrumentation.

 

The company will release its formal financial results on Jan. 26 after the stock market closes.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.